Yan Sun
Impact in
- Acoustics and Ultrasonics top 5%
- Oncology top 2%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Gastric Cancer Management and Outcomes 11
- Lung Cancer Treatments and Mutations 11
- Oncology 36
- Lung Cancer Research Studies 10
- Pancreatic and Hepatic Oncology Research 6
- Co-authors
- Xiangchun Li (2 shared papers)Yahui Jiang (1 shared paper)Meng Yang (1 shared paper)Shuhao Wang (1 shared paper)James Chih‐Hsin Yang (2 shared papers)Keunchil Park (2 shared papers)Vera Hirsh (1 shared paper)Robert M. Lorence (1 shared paper)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)Frontiers in Cardiovascular Medicine (3 papers)Modern Pathology (3 papers)Frontiers in Pediatrics (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yan Sun
122 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Acoustics and Ultrasonics 53
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.4k
- Health Informatics 51
- Cancer Research 571
Countries citing papers authored by Yan Sun
This map shows the geographic impact of Yan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Sun more than expected).
Fields of papers citing papers by Yan Sun
This network shows the impact of papers produced by Yan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Sun. The network helps show where Yan Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial Hit paper breakdown → | 2012 | 776 |
| 2 | 2020 | 290 | |
| 3 | 2014 | 153 | |
| 4 | 2007 | 106 | |
| 5 | 2011 | 99 | |
| 6 | 2016 | 88 | |
| 7 | 2009 | 85 | |
| 8 | 2014 | 84 | |
| 9 | 1998 | 83 | |
| 10 | 2015 | 78 | |
| 11 | 2018 | 68 | |
| 12 | 2011 | 66 | |
| 13 | 2020 | 66 | |
| 14 | 2008 | 61 | |
| 15 | 2014 | 60 | |
| 16 | 2013 | 60 | |
| 17 | 2014 | 57 | |
| 18 | 2012 | 46 | |
| 19 | 2011 | 46 | |
| 20 | 2011 | 46 |
About Yan Sun
Yan Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Epidemiology, having authored 130 papers that have together received 3.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (11 papers), Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (10 papers), Gastrointestinal Tumor Research and Treatment (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Neuroendocrine Tumor Research Advances (6 papers), Renal and related cancers (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). The work is most often cited by research in Acoustics and Ultrasonics (53 citations), Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.4k citations), Health Informatics (51 citations) and Cancer Research (571 citations). Yan Sun has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xiangchun Li, Yahui Jiang, Meng Yang, Shuhao Wang, James Chih‐Hsin Yang, Keunchil Park, Vera Hirsh, Robert M. Lorence, Tsu-Yi Chao and Vincent A. Miller. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Frontiers in Cardiovascular Medicine, Modern Pathology and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.